A study on immunological effects of L-canavanine
The Kobe Journal of Medical Sciences
|December 1, 1989
Summary
L-canavanine, an alfalfa seed amino acid, may induce lupus-like disease by affecting T cells. SLE patients show deficient T cells, potentially linked to L-canavanine
Area of Science:
- Immunology
- Biochemistry
- Toxicology
Background:
- Alfalfa seeds contain L-canavanine (LC), an arginine analog.
- LC induces a disease state resembling systemic lupus erythematosus (SLE) in primates.
- LC's in vitro effects suggest action on specific T cell subsets.
Purpose of the Study:
- To investigate the mechanism of L-canavanine's action on lymphocytes.
- To explore the role of T cells in LC-induced disease and SLE.
- To determine if LC affects intracellular calcium levels in lymphocytes.
Main Methods:
- In vitro experiments on T cells (CD8(-)Leu8(+)) and lymphocytes.
- Stimulation of lymphocytes from SLE patients and healthy controls with LC.
- Measurement of intracellular calcium levels ([Ca2+]i) in response to LC.
Main Results:
- L-canavanine primarily affects CD8(-)Leu8(+) T cells, regulating antibody synthesis and lymphocyte proliferation.
- Lymphocytes from SLE patients exhibited reduced responsiveness to LC stimulation.
- LC induced an increase in intracellular calcium levels ([Ca2+]i) in lymphocytes.
Conclusions:
- CD8(-)Leu8(+) T cells may be specifically deficient in SLE patients.
- The observed increase in intracellular calcium ([Ca2+]i) is a potential mechanism for LC's action on lymphocytes.
- LC's effects on T cells and calcium signaling offer insights into SLE pathogenesis.
More Related Videos
09:03Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
Published on: June 19, 2018
08:04A Rabbit Model of Aqueous-Deficient Dry Eye Disease Induced by Concanavalin A Injection into the Lacrimal Glands: Application to Drug Efficacy Studies
Published on: January 24, 2020
